- The trend backdrop is active with a 21-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is constructive, supporting the smart-money activity read.
- Latest weekly return ranks in the strongest part of its sector group.
1762
TAI
Week ended 07 Aug 2026
Weekly Investor Report
Chunghwa Chemical Synthesis & Biotech Co., Ltd. · Healthcare · Biotechnology
Latest close
35.75 TWD
9.7%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 12.7% above the Trend Line and sits at 56.2% of its 52-week range. The latest completed week returned 9.7%, after a -6.3% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
38
out of 100
Latest Close
35.75 TWD
7 Aug 2026
1W Return
9.7%
latest completed week
4W Return
-6.3%
short-term follow-through
12W Return
-0.3%
quarterly tape
Trend Breadth
40.4%
21 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
9.7%
Latest completed week; four-week move -6.3%.
Indicator stack
67/22
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 12.7% above the Trend Line and sits at 56.2% of its 52-week range. The latest completed week returned 9.7%, after a -6.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6312-week average 0.70
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.63Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -6.3% over four weeks, -0.3% over 12 weeks, and 27.5% over one year. The current trend has remained active for 21 consecutive weeks.
Performance by holding period
Active trend streak21 weeks
Active weeks in one year21
Trend breadth40.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.58Latest activity-pressure read.
Pressure change-214.3%Four-week change in activity pressure.
Leadership-9.10Latest relative-leadership reading.
RS change-5.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-20.1%Distance below the 52-week high.
13-week volatility7.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher16 of 2610 weeks finished lower.
Best week+37.2%Week of 8 May.
Worst week-18.0%Week of 12 Jun.
Latest week+9.7%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains8
Flat weeks0
Modest losses5
Sharp losses5
Recent vol7.4%13-week weekly-return volatility.
Base vol6.8%52-week weekly-return volatility.
Up/down split29/22Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank37 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank12 / 19
Group average-6.3%
Trend breadth31.6%
Trend31.6%active weekly trend signals
MD47.4%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape41/100
Trend, activity pressure, participation, and risk combine to a 41/100 tape read.
Indicator analysis63/100Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 0/12.
Activity pressure 0.63; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 35.75 TWD | 9.7% | 31.73 TWD | 38.88 TWD | -0.58 | -9.10 | 1.3M | On |
| 31 Jul 2026 | 32.60 TWD | -6.2% | 31.36 TWD | 39.13 TWD | -0.26 | -15.69 | 1.1M | On |
| 24 Jul 2026 | 34.75 TWD | -1.1% | 31.09 TWD | 39.40 TWD | 0.05 | -12.09 | 721.4K | On |
| 17 Jul 2026 | 35.15 TWD | -7.9% | 30.76 TWD | 39.68 TWD | 0.33 | -9.80 | 1.3M | On |
| 10 Jul 2026 | 38.15 TWD | 1.2% | 30.42 TWD | 40.01 TWD | 0.51 | -8.64 | 3.9M | On |
| 3 Jul 2026 | 37.70 TWD | 4.0% | 29.98 TWD | 40.33 TWD | 0.59 | -13.05 | 942.6K | On |
| 26 Jun 2026 | 36.25 TWD | 2.1% | 29.55 TWD | 40.62 TWD | 0.89 | -12.85 | 2.5M | On |
| 19 Jun 2026 | 35.50 TWD | 2.3% | 29.16 TWD | 40.92 TWD | 1.10 | -18.75 | 1.2M | On |
| 12 Jun 2026 | 34.70 TWD | -18.0% | 28.81 TWD | 41.27 TWD | 1.35 | -17.28 | 5.3M | On |
| 5 Jun 2026 | 42.30 TWD | 8.3% | 28.49 TWD | 41.59 TWD | 1.48 | -2.22 | 5.7M | On |
| 29 May 2026 | 39.05 TWD | 2.9% | 27.94 TWD | 41.88 TWD | 1.52 | -9.81 | 3.1M | On |
| 22 May 2026 | 37.95 TWD | 5.9% | 27.52 TWD | 42.20 TWD | 1.33 | -8.10 | 3.3M | On |
| 15 May 2026 | 35.85 TWD | -7.5% | 27.11 TWD | 42.53 TWD | 1.14 | -11.61 | 7.7M | On |
| 8 May 2026 | 38.75 TWD | 37.2% | 26.77 TWD | 42.91 TWD | 1.12 | -6.42 | 2.1M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.